Purchase Order 36C26123P1149
Award Date
6/1/23
Potential Completion Date
5/31/26
Potential Value
$110K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Clear Labs Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Clear Labs Inc. to provide a CLEAR DX Instrument for COVID-19 testing and sequencing. The $232,327.60 contract was awarded on March 16, 2021 and has a completion date of April 14, 2022. This contract is not designated as a set-aside. Clear Labs Inc. is a for-profit manufacturer that has previously provided COVID-19 genomic sequencing services, reagents, and instrumentation...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $467,144.72 firm-fixed-price delivery order contract to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, to provide COVID-19 genomic sequencing services and associated products. The contract runs through September 30, 2024, and is not designated as a set-aside. Clear Labs specializes in indexing the global food supply, setting standards for food integrity, and providing COVID-19 genomic...
Clear Labs Inc. was awarded a $259,184.24 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 for genomic sequencing services. The delivery order was issued against Clear Labs' indefinite delivery contract with the VA worth up to $16 million for COVID-19 genomic sequencing and related supplies from October 2022 through September 2027. Under this task order, Clear Labs will provide sequencing reagents,...
This federal contract award to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, is for COVID-19 genomic sequencing services and related products. The $403,128.72 firm-fixed-price delivery order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 and has an ultimate completion date of September 30, 2025. Additionally, Clear Labs holds a $16 million single-award indefinite delivery contract (IDV) with the VA Veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $625,064 firm fixed price purchase order to Clear Labs Inc. to provide COVID-19 genomic sequencing reagents for the Clear Labs DX analyzer. The place of performance for supplying these reagents is Palo Alto, California. The period of performance is from May 12, 2022 to September 30, 2022. This contract will facilitate VA's genomic sequencing efforts to support veterans' healthcare...
This $4,500 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company specializing in COVID-19 genomic sequencing services and related products. The contract is for the LYVE system relocation, with a completion date of May 27, 2024. Clear Labs has also received several other federal contracts and sub-awards from agencies like the Department of Veterans Affairs, National...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) awarded a $20,000 firm fixed price delivery order to Clear Labs Inc. for COVID-19 genomic sequencing services. The sequencing will be performed at Clear Labs' facility in San Carlos, California between August 21, 2023 and September 30, 2023. The delivery order was awarded under an unspecified multiple award contract vehicle to support the VA's efforts to monitor SARS-CoV-2...
This is a federal contract award to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, by the Centers for Disease Control and Prevention (CDC). The $77,088 firm-fixed-price purchase order is for the provision of COVID-19 reagents. The contract has no set-aside designation and is part of Clear Labs' broader work with federal agencies, including the Department of Veterans Affairs (VA) and the National Institute of Allergy and Infectious Diseases (NIAID), to support COVID-19...
This federal contract award, valued at $2,957,000.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company. The contract is for the development of in vitro diagnostics for biodefense, antimicrobial resistant infections, and emerging infectious diseases, as part of NIAID's Broad Agency Announcement BAA2023-1. This is a definitive contract with a cost-no-fee pricing type, and the period of...
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...